{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:46:59Z","timestamp":1778226419479,"version":"3.51.4"},"reference-count":178,"publisher":"Elsevier","isbn-type":[{"value":"9780128179291","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.pmbts.2019.11.002","type":"book-chapter","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:25:51Z","timestamp":1576830351000},"page":"43-83","source":"Crossref","is-referenced-by-count":12,"title":["Computational prediction and redesign of aberrant protein oligomerization"],"prefix":"10.1016","member":"78","reference":[{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/emboj\/18.6.1660","article-title":"A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking","volume":"18","author":"Stommel","year":"1999","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sbi.2008.12.003","article-title":"Linking folding and binding","volume":"19","author":"Wright","year":"2009","journal-title":"Curr Opin Struct Biol"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.sbi.2009.12.004","article-title":"Large conformational changes in proteins: signaling and other functions","volume":"20","author":"Grant","year":"2010","journal-title":"Curr Opin Struct Biol"},{"issue":"5924","key":"10.1016\/bs.pmbts.2019.11.002_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.1169375","article-title":"Protein dynamism and evolvability","volume":"324","author":"Tokuriki","year":"2009","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0035","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1208\/aapsj080366","article-title":"Protein aggregation and bioprocessing","volume":"8","author":"Cromwell","year":"2006","journal-title":"AAPS J"},{"issue":"29","key":"10.1016\/bs.pmbts.2019.11.002_bb0040","doi-asserted-by":"crossref","first-page":"11937","DOI":"10.1073\/pnas.0904191106","article-title":"Design of therapeutic proteins with enhanced stability","volume":"106","author":"Chennamsetty","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.copbio.2014.08.001","article-title":"Protein aggregation and its impact on product quality","volume":"30","author":"Roberts","year":"2014","journal-title":"Curr Opin Biotechnol"},{"issue":"27","key":"10.1016\/bs.pmbts.2019.11.002_bb0050","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1073\/pnas.1202866109","article-title":"General strategy for the generation of human antibody variable domains with increased aggregation resistance","volume":"109","author":"Dudgeon","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-chembioeng-062011-081052","article-title":"Engineering aggregation-resistant antibodies","volume":"3","author":"Perchiacca","year":"2012","journal-title":"Annu Rev Chem Biomol Eng"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-2836(02)00783-0","article-title":"Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils","volume":"322","author":"Ventura","year":"2002","journal-title":"J Mol Biol"},{"issue":"21","key":"10.1016\/bs.pmbts.2019.11.002_bb0065","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.2174\/0929867324666170705121754","article-title":"Advances in the prediction of protein aggregation propensity","volume":"26","author":"Pallares","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0070","series-title":"From Protein Structure to Function With Bioinformatics","first-page":"205","article-title":"Prediction of protein aggregation and amyloid formation","author":"Gra\u00f1a-Montes","year":"2017"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2007.05.015","article-title":"Folding versus aggregation: polypeptide conformations on competing pathways","volume":"469","author":"Jahn","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/bip.23020","article-title":"Hydrophobic-hydrophilic forces in protein folding","volume":"107","author":"Durell","year":"2017","journal-title":"Biopolymers"},{"issue":"pt A","key":"10.1016\/bs.pmbts.2019.11.002_bb0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2016.10.045","article-title":"Important amino acid residues involved in folding and binding of protein-protein complexes","volume":"94","author":"Kulandaisamy","year":"2017","journal-title":"Int J Biol Macromol"},{"issue":"7628","key":"10.1016\/bs.pmbts.2019.11.002_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature20416","article-title":"The activities of amyloids from a structural perspective","volume":"539","author":"Riek","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2859-4-11","article-title":"Sequence determinants of protein aggregation: tools to increase protein solubility","volume":"4","author":"Ventura","year":"2005","journal-title":"Microb Cell Fact"},{"issue":"suppl 4","key":"10.1016\/bs.pmbts.2019.11.002_bb0100","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1073\/pnas.212527999","article-title":"Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases","volume":"99","author":"Chiti","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jmb.2004.06.089","article-title":"Amyloid fibril formation by a partially structured intermediate state of alpha-chymotrypsin","volume":"342","author":"Pallares","year":"2004","journal-title":"J Mol Biol"},{"issue":"19","key":"10.1016\/bs.pmbts.2019.11.002_bb0110","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.1073\/pnas.0308249101","article-title":"Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case","volume":"101","author":"Ventura","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.redox.2017.03.027","article-title":"Protein aggregation into insoluble deposits protects from oxidative stress","volume":"12","author":"Carija","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0120","series-title":"Evolutionary Biology: Mechanisms and Trends","first-page":"103","article-title":"Protein aggregation acts as strong constraint during evolution","author":"Villar-Pique","year":"2012"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmb.2005.10.052","article-title":"Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP","volume":"355","author":"Abedini","year":"2006","journal-title":"J Mol Biol"},{"issue":"37","key":"10.1016\/bs.pmbts.2019.11.002_bb0130","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0135","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.str.2005.04.022","article-title":"Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation","volume":"13","author":"Parrini","year":"2005","journal-title":"Structure"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jmb.2005.11.035","article-title":"How evolutionary pressure against protein aggregation shaped chaperone specificity","volume":"355","author":"Rousseau","year":"2006","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/humu.20905","article-title":"Protein sequences encode safeguards against aggregation","volume":"30","author":"Reumers","year":"2009","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/biot.201000331","article-title":"Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes","volume":"6","author":"Castillo","year":"2011","journal-title":"Biotechnol J"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-61779-465-0_14","article-title":"AGGRESCAN: method, application, and perspectives for drug design","volume":"819","author":"de Groot","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jmb.2004.06.088","article-title":"comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins","volume":"342","author":"Linding","year":"2004","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.sbi.2011.11.007","article-title":"The two faces of Janus: functional interactions and protein aggregation","volume":"22","author":"Pastore","year":"2012","journal-title":"Curr Opin Struct Biol"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.11.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003291","article-title":"On the role of aggregation prone regions in protein evolution, stability, and enzymatic catalysis: insights from diverse analyses","volume":"9","author":"Buck","year":"2013","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1110\/ps.051741806","article-title":"Frequencies of hydrophobic and hydrophilic runs and alternations in proteins of known structure","volume":"15","author":"Schwartz","year":"2006","journal-title":"Protein Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0185","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1006\/jmbi.2000.3514","article-title":"Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis","volume":"296","author":"Broome","year":"2000","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058297","article-title":"The N-terminal helix controls the transition between the soluble and amyloid states of an FF domain","volume":"8","author":"Castillo","year":"2013","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/bs.pmbts.2019.11.002_bb0195","doi-asserted-by":"crossref","first-page":"9191","DOI":"10.1073\/pnas.0810364106","article-title":"Alpha-helix targeting reduces amyloid-beta peptide toxicity","volume":"106","author":"Nerelius","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7362","key":"10.1016\/bs.pmbts.2019.11.002_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"Alpha-synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ph10040089","article-title":"Propagation of fibrillar structural forms in proteins stopped by naturally occurring short polypeptide chain fragments","volume":"10","author":"Roterman","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"issue":"27","key":"10.1016\/bs.pmbts.2019.11.002_bb0210","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1073\/pnas.1017504108","article-title":"Structure-based prediction reveals capping motifs that inhibit beta-helix aggregation","volume":"108","author":"Bryan","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0215","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jmb.2008.03.020","article-title":"The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case","volume":"378","author":"Espargaro","year":"2008","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0220","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/ars.2013.5543","article-title":"Association between foldability and aggregation propensity in small disulfide-rich proteins","volume":"21","author":"Fraga","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2011.3936","article-title":"Contribution of disulfide bonds to stability, folding, and amyloid fibril formation: the PI3-SH3 domain case","volume":"16","author":"Grana-Montes","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-14-346","article-title":"Disulfide by design 2.0: a web-based tool for disulfide engineering in proteins","volume":"14","author":"Craig","year":"2013","journal-title":"BMC Bioinf"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.11.002_bb0235","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/molecules22091429","article-title":"The role of metal binding in the amyotrophic lateral sclerosis-related aggregation of copper-zinc superoxide dismutase","volume":"22","author":"Sirangelo","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fnmol.2017.00082","article-title":"Post-translational modifications and protein quality control in motor neuron and polyglutamine diseases","volume":"10","author":"Sambataro","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.11.002_bb0245","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1039\/b913099n","article-title":"Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations","volume":"5","author":"Tartaglia","year":"2009","journal-title":"Mol BioSyst"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tibs.2007.03.005","article-title":"Life on the edge: a link between gene expression levels and aggregation rates of human proteins","volume":"32","author":"Tartaglia","year":"2007","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0255","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/biot.201100014","article-title":"The aggregation properties of Escherichia coli proteins associated with their cellular abundance","volume":"6","author":"Castillo","year":"2011","journal-title":"Biotechnol J"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.genom.8.021307.110233","article-title":"Gene duplication: a drive for phenotypic diversity and cause of human disease","volume":"8","author":"Conrad","year":"2007","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0106-11","article-title":"Amyloid double trouble","volume":"38","author":"Hardy","year":"2006","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.11.002_bb0270","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/17460441.2019.1637413","article-title":"Computational re-design of protein structures to improve solubility","volume":"14","author":"Navarro","year":"2019","journal-title":"Expert Opin Drug Discovery"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrm3920","article-title":"Intrinsically disordered proteins in cellular signalling and regulation","volume":"16","author":"Wright","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"33","key":"10.1016\/bs.pmbts.2019.11.002_bb0280","doi-asserted-by":"crossref","first-page":"13392","DOI":"10.1073\/pnas.1304749110","article-title":"Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues","volume":"110","author":"Das","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"suppl 2","key":"10.1016\/bs.pmbts.2019.11.002_bb0285","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1186\/1471-2164-9-S2-S26","article-title":"Short linear motifs recognized by SH2, SH3 and Ser\/Thr kinase domains are conserved in disordered protein regions","volume":"9","author":"Ren","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnagi.2015.00018","article-title":"Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders","volume":"7","author":"Uversky","year":"2015","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cell.2006.04.014","article-title":"Molecular chaperones and protein quality control","volume":"125","author":"Bukau","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0300","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/ijms19051384","article-title":"The disordered C-terminus of yeast Hsf1 contains a cryptic low-complexity amyloidogenic region","volume":"19","author":"Pujols","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1196\/annals.1391.011","article-title":"Chaperones and proteases\u2014guardians of protein integrity in eukaryotic organelles","volume":"1113","author":"Leidhold","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.ircmb.2016.08.011","article-title":"Effects of intrinsic and extrinsic factors on aggregation of physiologically important intrinsically disordered proteins","volume":"329","author":"Breydo","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2105-8-65","article-title":"AGGRESCAN: a server for the prediction and evaluation of \u201chot spots\u201d of aggregation in polypeptides","volume":"8","author":"Conchillo-Sole","year":"2007","journal-title":"BMC Bioinf"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.11.002_bb0320","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nbt1012","article-title":"Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins","volume":"22","author":"Fernandez-Escamilla","year":"2004","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0325","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.sbi.2006.01.011","article-title":"Protein aggregation and amyloidosis: confusion of the kinds?","volume":"16","author":"Rousseau","year":"2006","journal-title":"Curr Opin Struct Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.11.002_bb0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/embor.2011.116","article-title":"Prediction of amyloid aggregation in vivo","volume":"12","author":"Belli","year":"2011","journal-title":"EMBO Rep"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0335","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/bioinformatics\/btp691","article-title":"FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence","volume":"26","author":"Garbuzynskiy","year":"2010","journal-title":"Bioinformatics"},{"issue":"web server issue","key":"10.1016\/bs.pmbts.2019.11.002_bb0340","doi-asserted-by":"crossref","first-page":"W301","DOI":"10.1093\/nar\/gku399","article-title":"PASTA 2.0: an improved server for protein aggregation prediction","volume":"42","author":"Walsh","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nmeth.1432","article-title":"Exploring the sequence determinants of amyloid structure using position-specific scoring matrices","volume":"7","author":"Maurer-Stroh","year":"2010","journal-title":"Nat Methods"},{"issue":"13","key":"10.1016\/bs.pmbts.2019.11.002_bb0350","doi-asserted-by":"crossref","first-page":"i34","DOI":"10.1093\/bioinformatics\/btr238","article-title":"A method for probing the mutational landscape of amyloid structure","volume":"27","author":"O'Donnell","year":"2011","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054175","article-title":"A consensus method for the prediction of \u2018aggregation-prone\u2019 peptides in globular proteins","volume":"8","author":"Tsolis","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0360","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","article-title":"Mechanisms of neuronal degeneration in Alzheimer's disease","volume":"16","author":"Yankner","year":"1996","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720506775697098","article-title":"Has the amyloid cascade hypothesis for Alzheimer's disease been proved?","volume":"3","author":"Hardy","year":"2006","journal-title":"Curr Alzheimer Res"},{"issue":"5300","key":"10.1016\/bs.pmbts.2019.11.002_bb0370","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","article-title":"Alzheimer's disease: genotypes, phenotypes, and treatments","volume":"275","author":"Selkoe","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0375","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(93)90312-E","article-title":"Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide","volume":"75","author":"Haass","year":"1993","journal-title":"Cell"},{"issue":"13","key":"10.1016\/bs.pmbts.2019.11.002_bb0380","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0385","doi-asserted-by":"crossref","first-page":"a024083","DOI":"10.1101\/cshperspect.a024083","article-title":"Molecular structure of aggregated amyloid-beta: insights from solid-state nuclear magnetic resonance","volume":"6","author":"Tycko","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"43","key":"10.1016\/bs.pmbts.2019.11.002_bb0390","doi-asserted-by":"crossref","first-page":"40810","DOI":"10.1074\/jbc.M205659200","article-title":"Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling","volume":"277","author":"T\u00f6r\u00f6k","year":"2002","journal-title":"J Biol Chem"},{"issue":"47","key":"10.1016\/bs.pmbts.2019.11.002_bb0395","doi-asserted-by":"crossref","first-page":"18349","DOI":"10.1073\/pnas.0806270105","article-title":"Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils","volume":"105","author":"Paravastu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0400","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/bi051952q","article-title":"Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils","volume":"45","author":"Petkova","year":"2006","journal-title":"Biochemistry"},{"issue":"40","key":"10.1016\/bs.pmbts.2019.11.002_bb0405","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1021\/ja2035859","article-title":"A new structural model of Abeta40 fibrils","volume":"133","author":"Bertini","year":"2011","journal-title":"J Am Chem Soc"},{"issue":"30","key":"10.1016\/bs.pmbts.2019.11.002_bb0410","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/jacs.6b05129","article-title":"Atomic resolution structure of monomorphic Abeta42 amyloid fibrils","volume":"138","author":"Colvin","year":"2016","journal-title":"J Am Chem Soc"},{"issue":"48","key":"10.1016\/bs.pmbts.2019.11.002_bb0415","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1073\/pnas.0506723102","article-title":"3D structure of Alzheimer's amyloid-beta(1-42) fibrils","volume":"102","author":"Luhrs","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0420","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jmb.2006.06.066","article-title":"Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange\u2014mass spectrometry with on-line proteolytic fragmentation","volume":"361","author":"Kheterpal","year":"2006","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0425","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1742-4658.2005.05102.x","article-title":"Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities","volume":"273","author":"de Groot","year":"2006","journal-title":"FEBS J"},{"issue":"45","key":"10.1016\/bs.pmbts.2019.11.002_bb0430","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1021\/bi0011330","article-title":"Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR","volume":"39","author":"Balbach","year":"2000","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0435","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jmb.2003.11.008","article-title":"Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis","volume":"335","author":"Williams","year":"2004","journal-title":"J Mol Biol"},{"issue":"50","key":"10.1016\/bs.pmbts.2019.11.002_bb0440","doi-asserted-by":"crossref","first-page":"52781","DOI":"10.1074\/jbc.M406262200","article-title":"Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement","volume":"279","author":"Morimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0445","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1472-6807-5-18","article-title":"Prediction of \u201chot spots\u201d of aggregation in disease-linked polypeptides","volume":"5","author":"Sanchez de Groot","year":"2005","journal-title":"BMC Struct Biol"},{"issue":"6645","key":"10.1016\/bs.pmbts.2019.11.002_bb0450","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0455","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0460","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0465","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J Res Med Sci"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2019.11.002_bb0470","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jnc.13249","article-title":"Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies","volume":"139","author":"Villar-Pique","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.11.002_bb0480","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0485","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson's disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0490","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1100\/2011\/371893","article-title":"Interaction between alpha-synuclein and other proteins in neurodegenerative disorders","volume":"11","author":"Jellinger","year":"2011","journal-title":"ScientificWorldJournal"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0495","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090659","article-title":"Unlike twins: an NMR comparison of two alpha-synuclein polymorphs featuring different toxicity","volume":"9","author":"Gath","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0505","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12104-013-9526-y","article-title":"Yet another polymorph of alpha-synuclein: solid-state sequential assignments","volume":"8","author":"Gath","year":"2014","journal-title":"Biomol NMR Assign"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0510","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jmb.2011.06.026","article-title":"Structured regions of alpha-synuclein fibrils include the early-onset Parkinson's disease mutation sites","volume":"411","author":"Comellas","year":"2011","journal-title":"J Mol Biol"},{"issue":"25","key":"10.1016\/bs.pmbts.2019.11.002_bb0515","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","article-title":"The fold of alpha-synuclein fibrils","volume":"105","author":"Vilar","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"34","key":"10.1016\/bs.pmbts.2019.11.002_bb0520","doi-asserted-by":"crossref","first-page":"24970","DOI":"10.1074\/jbc.M700368200","article-title":"Investigation of alpha-synuclein fibril structure by site-directed spin labeling","volume":"282","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1016\/bs.pmbts.2019.11.002_bb0525","doi-asserted-by":"crossref","first-page":"37530","DOI":"10.1074\/jbc.M305266200","article-title":"Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling","volume":"278","author":"Der-Sarkissian","year":"2003","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.11.002_bb0530","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.11.002_bb0535","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0540","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1471-4159.2001.00408.x","article-title":"Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity","volume":"78","author":"Bodles","year":"2001","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0545","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jmb.2009.03.021","article-title":"The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast","volume":"389","author":"Vamvaca","year":"2009","journal-title":"J Mol Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.11.002_bb0550","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophys J"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.11.002_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075018","article-title":"Mechanistic insight into the relationship between N-terminal acetylation of alpha-synuclein and fibril formation rates by NMR and fluorescence","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"issue":"suppl 3","key":"10.1016\/bs.pmbts.2019.11.002_bb0560","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.2337\/diabetes.53.suppl_3.S233","article-title":"Amylin agonists: a novel approach in the treatment of diabetes","volume":"53","author":"Schmitz","year":"2004","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.11.002_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161243","article-title":"Structural characterization of fibrils from recombinant human islet amyloid polypeptide by solid-state NMR: the central FGAILS segment is part of the beta-sheet core","volume":"11","author":"Weirich","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056467","article-title":"Amide proton solvent protection in amylin fibrils probed by quenched hydrogen exchange NMR","volume":"8","author":"Alexandrescu","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0575","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","article-title":"Fibril structure of human islet amyloid polypeptide","volume":"287","author":"Bedrood","year":"2012","journal-title":"J Biol Chem"},{"issue":"47","key":"10.1016\/bs.pmbts.2019.11.002_bb0580","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","article-title":"Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR","volume":"46","author":"Luca","year":"2007","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0585","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmb.2005.02.029","article-title":"The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin","volume":"348","author":"Kajava","year":"2005","journal-title":"J Mol Biol"},{"issue":"2\u20133","key":"10.1016\/bs.pmbts.2019.11.002_bb0590","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/jsbi.2000.4268","article-title":"Amyloid fibril formation from full-length and fragments of amylin","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J Struct Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0595","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1047-8477(02)00630-5","article-title":"Identification of minimal peptide sequences in the (8\u201320) domain of human islet amyloid polypeptide involved in fibrillogenesis","volume":"141","author":"Scrocchi","year":"2003","journal-title":"J Struct Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0600","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1021\/bi981658g","article-title":"Effects of sequential proline substitutions on amyloid formation by human amylin20\u201329","volume":"38","author":"Moriarty","year":"1999","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0605","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jmb.2017.03.014","article-title":"Prediction and reduction of the aggregation of monoclonal antibodies","volume":"429","author":"van der Kant","year":"2017","journal-title":"J Mol Biol"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0610","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.biophys.37.032807.125924","article-title":"Intrinsically disordered proteins in human diseases: introducing the D2 concept","volume":"37","author":"Uversky","year":"2008","journal-title":"Annu Rev Biophys"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0615","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jmb.2016.01.009","article-title":"Comparison of the aggregation of homologous beta2-microglobulin variants reveals protein solubility as a key determinant of amyloid formation","volume":"428","author":"Pashley","year":"2016","journal-title":"J Mol Biol"},{"issue":"29","key":"10.1016\/bs.pmbts.2019.11.002_bb0620","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1073\/pnas.0403756101","article-title":"An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril","volume":"101","author":"Ivanova","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0625","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4939-8820-4_21","article-title":"SolubiS: optimizing protein solubility by minimal point mutations","volume":"1873","author":"van der Kant","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"web server issue","key":"10.1016\/bs.pmbts.2019.11.002_bb0630","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0635","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jmb.2007.02.058","article-title":"Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein","volume":"368","author":"Ellisdon","year":"2007","journal-title":"J Mol Biol"},{"issue":"25","key":"10.1016\/bs.pmbts.2019.11.002_bb0640","doi-asserted-by":"crossref","first-page":"16888","DOI":"10.1074\/jbc.M601470200","article-title":"The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step","volume":"281","author":"Ellisdon","year":"2006","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.11.002_bb0645","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/pro.698","article-title":"Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein","volume":"20","author":"Saunders","year":"2011","journal-title":"Protein Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0650","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jmb.2004.09.065","article-title":"Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3","volume":"344","author":"Masino","year":"2004","journal-title":"J Mol Biol"},{"issue":"40","key":"10.1016\/bs.pmbts.2019.11.002_bb0655","doi-asserted-by":"crossref","first-page":"24190","DOI":"10.1074\/jbc.M115.659532","article-title":"Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease","volume":"290","author":"Lupton","year":"2015","journal-title":"J Biol Chem"},{"issue":"W1","key":"10.1016\/bs.pmbts.2019.11.002_bb0660","doi-asserted-by":"crossref","first-page":"W300","DOI":"10.1093\/nar\/gkz321","article-title":"Aggrescan3D (A3D) 2.0: prediction and engineering of protein solubility","volume":"47","author":"Kuriata","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.11.002_bb0665","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/bip.21210","article-title":"Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites","volume":"91","author":"Nicastro","year":"2009","journal-title":"Biopolymers"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0670","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1096\/fj.10-161208","article-title":"Functional interactions as a survival strategy against abnormal aggregation","volume":"25","author":"Masino","year":"2011","journal-title":"FASEB J"},{"issue":"25","key":"10.1016\/bs.pmbts.2019.11.002_bb0675","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1073\/pnas.0812414106","article-title":"Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins","volume":"106","author":"Pechmann","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000476","article-title":"Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases","volume":"5","author":"Castillo","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0685","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: a multifaceted protein","volume":"5","author":"Vieira","year":"2014","journal-title":"Biomol Concepts"},{"issue":"6 pt 1","key":"10.1016\/bs.pmbts.2019.11.002_bb0690","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.lpm.2013.03.004","article-title":"Senile systemic amyloidosis: definition, diagnosis, why thinking about?","volume":"42","author":"Damy","year":"2013","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0695","first-page":"11","article-title":"Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights","volume":"7","author":"Koike","year":"2019","journal-title":"Biomedicine"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0700","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0166-2236(89)90162-8","article-title":"Familial amyloidotic polyneuropathy","volume":"12","author":"Benson","year":"1989","journal-title":"Trends Neurosci"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.11.002_bb0705","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11886-017-0911-5","article-title":"Transthyretin cardiac amyloidosis","volume":"19","author":"Mankad","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0710","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-019-08609-z","article-title":"A molecular mechanism for transthyretin amyloidogenesis","volume":"10","author":"Yee","year":"2019","journal-title":"Nat Commun"},{"issue":"5607","key":"10.1016\/bs.pmbts.2019.11.002_bb0715","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstrom","year":"2003","journal-title":"Science"},{"issue":"24","key":"10.1016\/bs.pmbts.2019.11.002_bb0720","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0725","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1038\/ncomms10787","article-title":"Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity","volume":"7","author":"Sant'Anna","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0730","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm030347n","article-title":"Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis","volume":"47","author":"Adamski-Werner","year":"2004","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0735","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0740","doi-asserted-by":"crossref","first-page":"44709","DOI":"10.1038\/srep44709","article-title":"Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation","volume":"7","author":"Sant'Anna","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddy323","article-title":"Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses","volume":"28","author":"Medina-Carmona","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"22","key":"10.1016\/bs.pmbts.2019.11.002_bb0750","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","article-title":"Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)","volume":"244","author":"McCord","year":"1969","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0755","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2976\/1.2995726","article-title":"SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease","volume":"2","author":"Nordlund","year":"2008","journal-title":"HFSP J"},{"issue":"18","key":"10.1016\/bs.pmbts.2019.11.002_bb0760","doi-asserted-by":"crossref","first-page":"15932","DOI":"10.1074\/jbc.M112088200","article-title":"Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper\/zinc superoxide dismutase","volume":"277","author":"Rodriguez","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0765","first-page":"169","article-title":"Activity and stability of recombinant human superoxide dismutase in buffer solutions and hypothermic perfusates","volume":"42","author":"Senoo","year":"1988","journal-title":"Acta Med Okayama"},{"issue":"18","key":"10.1016\/bs.pmbts.2019.11.002_bb0770","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1074\/jbc.M112087200","article-title":"Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis","volume":"277","author":"Hayward","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010064","article-title":"Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species","volume":"5","author":"Svensson","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.11.002_bb0780","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1074\/jbc.M210419200","article-title":"Familial amyotrophic lateral sclerosis mutants of copper\/zinc superoxide dismutase are susceptible to disulfide reduction","volume":"278","author":"Tiwari","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0785","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506120600960486","article-title":"FALS mutations in Cu, Zn superoxide dismutase destabilize the dimer and increase dimer dissociation propensity: a large-scale thermodynamic analysis","volume":"13","author":"Khare","year":"2006","journal-title":"Amyloid"},{"issue":"25","key":"10.1016\/bs.pmbts.2019.11.002_bb0790","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1074\/jbc.M109.086074","article-title":"SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability","volume":"285","author":"Bystrom","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0795","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jmb.2010.04.019","article-title":"Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants","volume":"399","author":"Munch","year":"2010","journal-title":"J Mol Biol"},{"issue":"17","key":"10.1016\/bs.pmbts.2019.11.002_bb0800","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1021\/bi030246r","article-title":"An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis","volume":"43","author":"Ray","year":"2004","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.11.002_bb0805","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1073\/pnas.0408277102","article-title":"Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation","volume":"102","author":"Ray","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.11.002_bb0810","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/pro.2803","article-title":"Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1","volume":"24","author":"Broom","year":"2015","journal-title":"Protein Sci"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.11.002_bb0815","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023523","article-title":"Protein quality control in health and disease","volume":"9","author":"Dubnikov","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.11.002_bb0820","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbamcr.2013.06.031","article-title":"Protein quality control and elimination of protein waste: the role of the ubiquitin-proteasome system","volume":"1843","author":"Amm","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"50","key":"10.1016\/bs.pmbts.2019.11.002_bb0825","doi-asserted-by":"crossref","first-page":"21447","DOI":"10.1073\/pnas.1006424107","article-title":"Effects of pH on aggregation kinetics of the repeat domain of a functional amyloid, Pmel17","volume":"107","author":"Pfefferkorn","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0830","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.celrep.2012.09.036","article-title":"Cellular strategies for regulating functional and nonfunctional protein aggregation","volume":"2","author":"Gsponer","year":"2012","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0835","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1007564601210","article-title":"Stability of human serum albumin during bioprocessing: denaturation and aggregation during processing of albumin paste","volume":"17","author":"Lin","year":"2000","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0840","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jps.20079","article-title":"Challenges in the development of high protein concentration formulations","volume":"93","author":"Shire","year":"2004","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.11.002_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.09.049","article-title":"Commentary: new perspectives on protein aggregation during biopharmaceutical development","volume":"552","author":"Shah","year":"2018","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0850","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J Immunotoxicol"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0855","author":"FDA"},{"key":"10.1016\/bs.pmbts.2019.11.002_bb0860","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.copbio.2018.01.007","article-title":"Debottlenecking protein secretion and reducing protein aggregation in the cellular host","volume":"53","author":"Zhou","year":"2018","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0865","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejps.2003.12.010","article-title":"Effects of sucrose on rFVIIa aggregation and methionine oxidation","volume":"21","author":"Soenderkaer","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.11.002_bb0870","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11095-018-2368-7","article-title":"Formulation stabilization and disaggregation of bevacizumab, ranibizumab and aflibercept in dilute solutions","volume":"35","author":"Giannos","year":"2018","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.11.002_bb0875","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/0929866054696109","article-title":"Review: why is arginine effective in suppressing aggregation?","volume":"12","author":"Tsumoto","year":"2005","journal-title":"Protein Pept Lett"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.11.002_bb0880","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/microorganisms6020047","article-title":"Polyionic tags as enhancers of protein solubility in recombinant protein expression","volume":"6","author":"Paraskevopoulou","year":"2018","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.11.002_bb0885","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1021\/acs.molpharmaceut.8b00341","article-title":"Combining structural aggregation propensity and stability predictions to re-design protein solubility","volume":"15","author":"Gil-Garcia","year":"2018","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.11.002_bb0890","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/07853890802698842","article-title":"Challenges in monoclonal antibody-based therapies","volume":"41","author":"Samaranayake","year":"2009","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.11.002_bb0895","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0958-1669(00)00152-X","article-title":"Phage display in pharmaceutical biotechnology","volume":"11","author":"Sidhu","year":"2000","journal-title":"Curr Opin Biotechnol"}],"container-title":["Progress in Molecular Biology and Translational Science","Oligomerization in Health and Disease: From Enzymes to G Protein-Coupled Receptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319301991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319301991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:01:39Z","timestamp":1761796899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117319301991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128179291"],"references-count":178,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2019.11.002","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}